Risk factors for vancomycin-resistant enterococcus colonization in hematologic patients;Faktori rizika od kolonizacije vankomicin-rezistentnog enterococcus-a kod hematoloških bolesnika

Vojnosanitetski Pregled

Volumn 70, Issue 12, 2013, Pages 1109-1116

  Mioljević, Vesna ^a   Marković Denić, Ljiljana ^a   Vidović, Ana ^b   Jovanović, Milica ^a   Tošić, Tanja ^a   Tomin, Dragica ^b  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Bacterial; Drug resistance; Enterococcus faecium; Hematologic diseases; Risk factors; Vancomycin

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; GLYCOPEPTIDE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; DISK DIFFUSION; FEMALE; HEMATOLOGY; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATHOGENESIS; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CROSS INFECTION; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC DISEASES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; VANCOMYCIN RESISTANCE; YOUNG ADULT;

EID: 84888782103     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1312109M     Document Type: Article

References (31)

1. Willems RJ, Bonten MJ. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity. Curr Opin Infect Dis 2007; 20(4): 384-90.
2. Sujatha S, Praharaj I. Glycopeptide resistance in gram-positive cocci: a review. Interdiscip Perspect Infect Dis 2012; 2012: 781679.
3. Surveillance report. Antimicrobial resistance surveillance in Europe, 2009. Available from: www.ecdc.europa.eu/en//1011 SUR annual EARS Net 2 009
4. Alias C, Murray B. The rise of the Enterococcus: beyond van-comycin resistance. Nat Rev Microbiol 2012; 10(4): 266-78.
5. Low DE, Keller N, Barth A, Jones RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32 Suppl 2: S133-45.
6. Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A, et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 2008; 13(47). pii: 19046.
7. ECDC. Antimicrobial resistance surveillance in Europe 2010. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Available from: http://repositorio.insa.pt/handle/10400.18/702
8. National Nosocomial Infections Surveillance (NNIS) System Report data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32(8): 470-85.
9. Achenbach C, Flores E, Farewell P, Pitrak D, Weber G Prevalence of risk factors for colonization with vancomicyn-resistant enterococcus among human immunodeficiency virus positive outpatients. Infect Control Hosp Epidemiol 2006; 27(1): 102-4.
10. Sakka V, Tsiodras S, Galani L, Antoniadou A, Souli M, Galani I, et al. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Clin Microbiol Infect 2008; 14(1): 14-21.
11. Tacconelli E, Cataldo MA. Vancomycin-resistant enterococci (VRE): transmission and control. Int J Antimicrob Agents 2008; 31: 99-106.
12. Muto CA, Jemigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Bqyce JM, et al. SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains of Staphylococcus aureus and Enterococcus spp. Infect Control Hosp Epidemiol 2003; 24(5); 362-86.
13. Yoon YK, Lee SE, Lee J, Kim HJ, Kim JY, Park DW, et al. Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study. J Antimicrob Chemother 2011; 66(8): 1831-8.
14. CLSI. Performance Standards for Antimicrobial Disk Susceptibility Testing; Seventeenth Informational Supplement M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute; 2007.
15. CLSI. Performance Standards for Antimicrobial Disk Susceptibility Tests; M02-A10. Approved Standard - Tenthth edition. Wayne, PA: Clinical and Laboratory Standards Institute; 2009.
16. Gambarotto K, Ploy MC, Turlure P, Gre'laud C, Martin C, Hordes-souk D, et al. Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospital-ized controls in a cattle-rearing area of France. J Clin Micro-biol 2000; 38(2): 620-4.
17. van den Braak N, Ott A, van Belkum A, Kluytmans JA, Koeleman JG, Spanjaard L, et al. Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in The Netherlands. Infect Control Hosp Epidemiol 2000; 21(8): 520-4.
18. Almyroudis NG, Lesse AJ, Hahn T, Samonis G, Hazamy PA, Wongkittiroch K, et al. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies. Infect Control Hosp Epidemiol 2011; 32(5): 490-6.
19. Eiss BJ, Vehreschild JJ, Comely OA, Hallek M, Fätkenheuer G, Wisplinghojf H, et al. Intestinal colonisation and blood stream infections due to vancomycin-resistantentero-cocci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection 2012; 40(6): 613-9.
20. Matar MJ, Tarrand J, Raad I, Rolston KV. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control 2006; 34(8): 534-6.
21. Suntharam N, Eankford MG, Trick WE, Peterson ER, Noskin GA. Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients. Diagn Microbiol Infect Dis 2002; 43(3): 183-8.
22. Mirovič V, Fomanovič B, Konstantinovič S. The frequency of resistance to antibiotics of most frequently isolated bacteria from blood cultures during the period 1997-2002. Vojnosanit Pregl 2004; 61(4): 391-7. (Serbian)
23. Cheong HJ, Song JY, Eom JS, Kim WJ, Choi SJ, Choi JH, et al. Colonization rate, risk factor for acquisition, and genetic sen-sity of vancomicyn-resistant enterococci (VRE) isolated from culture of patients in intensive care unit from Korea. Korean J Infect Dis 2002; 34: 276-84.
24. Metallidis S, Chatzidimitriou M, Tsona A, Bisiklis A, Eazaraki G, Koumentaki E, et al. Vancomicyn-Resistant Enterococci, Colonizing the Intenstinal Tract of Patients in a University Hospital in Greece. Braz J Infect Dis 2006; 10(3): 179-84.
25. Song JY, Cheong HJ, Jo YM, Choi WS, Noh JY, Heo JY, et al. Vancomicyn-Resistant Enterococci colonization before ad-mision to the intensive care unit: A clinico-epidemiological analysis. Am J Infect Control 2009; 37(9): 734-40.
26. Padiglione AA, Wolfe R, Grabsch EA, Olden D, Pearson S, Franklin C, et al. Risk Factors for New Detection of Vancomycin-Resistant Enterococci in Acute-Care Hospitals That Employ Strict Infection Control Procedures. Antimocrob Agents Chemother 2003; 47(8): 2492-8.
27. Carmely Y, Samore MH, Huskins C The association between antecedent vancomicyn teatment and hospital-acquired van-comicyn-resistent eneterococci; a meta analysis. Arch Intern Med 1999; 159(20): 2461-8.
28. Ostrovsky BE, Venkataraman E, D'Agata EM, Gold HS, De Gi-rolami, Samore MH. Vancomicyn-resistant enterococci intensive care units: high freguency of stool carrige during a non outbreak period. Arch Intern Med 1999; 159(13): 1467-72
29. de Bruin MA, Riley LW. Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review. BMC Infect Dis 2007; 7: 24-35.
30. Stiefel U, Paterson DE, Pultz NJ, Gordon SM, Aron DC, Donskey CJ. Effect of the increasing use of piperacillin/tazobactam on the incidence of vancomycin-resistant enterococci in four academic medical centers. Infect Control Hosp Epidemiol 2004; 25(5): 380-3.
31. Hidron AL, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, at al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29(11): 996-1011.